摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-chloromethyl-3-methoxynaphthalene | 153958-79-3

中文名称
——
中文别名
——
英文名称
2-chloromethyl-3-methoxynaphthalene
英文别名
2-methoxy-3-(chloromethyl)naphthalene;2-(Chloromethyl)-3-methoxynaphthalene
2-chloromethyl-3-methoxynaphthalene化学式
CAS
153958-79-3
化学式
C12H11ClO
mdl
——
分子量
206.672
InChiKey
CQSZAJQHIUQXOT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    328.2±17.0 °C(Predicted)
  • 密度:
    1.179±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.5
  • 重原子数:
    14
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.17
  • 拓扑面积:
    9.2
  • 氢给体数:
    0
  • 氢受体数:
    1

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-chloromethyl-3-methoxynaphthalene盐酸羟胺sodium methylate 作用下, 以 甲醇二甲基亚砜乙腈 为溶剂, 反应 20.5h, 生成 N-Hydroxy-2-(3-methoxy-naphthalen-2-yl)-acetamidine
    参考文献:
    名称:
    Antihyperglycemic activity of novel naphthalenylmethyl-3H-1,2,3,5-oxathiadiazole 2-oxides
    摘要:
    A series of naphthalenyl 3H-1,2,3,5-oxathiadiazole 2-oxides was prepared and tested for antihyperglycemic activity in the db/db mouse, a model for type 2 (non-insulin dependent) diabetes mellitus. Substitution at the 1-, 5-, or 8-positions of the naphthalene ring with a halogen was found to be beneficial to antihyperglycemic activity. 4-[(5-Chloronaphthalen-2-yl)methyl]-3H-1,2,3,5-oxathiadiazole 2-oxide (45), one of the most potent compounds in this series, was selected for further pharmacological evaluation.
    DOI:
    10.1021/jm00069a006
  • 作为产物:
    描述:
    3-甲氧基-2-萘甲醇氯化亚砜 、 zinc(II) chloride 作用下, 以 1,4-二氧六环 为溶剂, 反应 0.67h, 生成 2-chloromethyl-3-methoxynaphthalene
    参考文献:
    名称:
    Antihyperglycemic activity of novel naphthalenylmethyl-3H-1,2,3,5-oxathiadiazole 2-oxides
    摘要:
    A series of naphthalenyl 3H-1,2,3,5-oxathiadiazole 2-oxides was prepared and tested for antihyperglycemic activity in the db/db mouse, a model for type 2 (non-insulin dependent) diabetes mellitus. Substitution at the 1-, 5-, or 8-positions of the naphthalene ring with a halogen was found to be beneficial to antihyperglycemic activity. 4-[(5-Chloronaphthalen-2-yl)methyl]-3H-1,2,3,5-oxathiadiazole 2-oxide (45), one of the most potent compounds in this series, was selected for further pharmacological evaluation.
    DOI:
    10.1021/jm00069a006
点击查看最新优质反应信息

文献信息

  • Synthesis and fluoride-induced chemiluminescent decomposition of bicyclic dioxetanes substituted with a 2-hydroxynaphthyl group
    作者:Naoyuki Hoshiya、Natsuki Fukuda、Hidetoshi Maeda、Nobuko Watanabe、Masakatsu Matsumoto
    DOI:10.1016/j.tet.2006.03.082
    日期:2006.6
    efficiency, and that dioxetane 1aA exhibited chemiluminescence with the highest efficiency among those for the oxynaphthyl-substituted dioxetanes hitherto known. The significant change in chemiluminescent efficiency depending on the substitution pattern was clarified to be attributed to the marked change in singlet-chemiexcitation efficiency for charge-transfer-induced chemiluminescence (CTICL) of 1aA–1eA
    合成了5个带有2-羟基萘基的双环二氧杂环丁烷1aA - 1eA,并使用四丁基氟化铵(TBAF)作为DMSO中的碱检查了它们的化学发光分解。发现这些二氧杂环丁烷完全保持了作为萘环上的引发剂的羟基的取代模式与其化学发光效率之间的'奇/偶'关系,并且二氧环乙烷1aA在迄今为止已知的氧萘基取代的二氧杂环丁烷中,化学发光显示出最高的化学发光效率。化学发光效率的显着变化取决于取代模式,已明确归因于1aA – 1eA电荷转移诱导的化学发光(CTICL)的单重态化学激发效率的显着变化。关于CTICL分解的速率,观察到1aA – 1dA的“奇/偶”关系。
  • Amides tricycliques, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent
    申请人:ADIR ET COMPAGNIE
    公开号:EP0737670A1
    公开(公告)日:1996-10-16
    L'invention concerne les composés de formule (I) : dans laquelle R7, R8, Y, n et A sont tels que définis dans la description. Médicaments.
    本发明涉及式 (I) 化合物: 其中 R7、R8、Y、n 和 A 如说明书中所定义。 药物。
  • COMPOUNDS FOR SEPARATION OF RARE EARTH ELEMENTS, METHOD OF SEPARATION, AND USE THEREOF
    申请人:Ustav organicke chemie a biochemie AV CR, v.v.i.
    公开号:EP3492460A1
    公开(公告)日:2019-06-05
    The present invention relates to the use of the compounds of general formula (I): wherein X, Y, Z, L, R and R1 are as described herein; for chromatographic separation of rare earth elements, as well as to the method of the separation of rare earth elements.
    本发明涉及通式(I)化合物的用途: 其中 X、Y、Z、L、R 和 R1 如本文所述; 以及分离稀土元素的方法。
  • Design and Synthesis of 2-Naphthoate Esters as Selective Dopamine D<sub>4</sub> Antagonists
    作者:Izzy Boyfield、Thomas H. Brown、Martyn C. Coldwell、David G. Cooper、Michael S. Hadley、Jim J. Hagan、Maureen A. Healy、Amanda Johns、Ron J. King、Derek N. Middlemiss、David J. Nash、Graham J. Riley、Emma E. Scott、Stephen A. Smith、Geoffrey Stemp
    DOI:10.1021/jm960017l
    日期:1996.1.1
  • COMPOUNDS FOR SEPARATION OF RARE EARTH ELEMENTS AND S-, P-, D- METALS, METHOD OF SEPARATION, AND USE THEREOF
    申请人:Ustav Organicke Chemie a Biochemie AV CR, v.v.i.
    公开号:EP3717466B1
    公开(公告)日:2022-01-05
查看更多